Androgen receptor modulators and methods of use thereof

Details for Australian Patent Application No. 2004238238 (hide)

International Classifications

Event Publications

10 November 2005 PCT application entered the National Phase

PCT publication WO2004/100874 Priority application(s): WO2004/100874

16 July 2009 Application Accepted

Published as AU-B-2004238238

24 September 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 25 Aug 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

14 January 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Aug 2009

21 January 2010 Amendment Made

The nature of the amendment is: Amend the Patentee from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

21 January 2010 Standard Patent Sealed

11 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.